[
  {
    "title": "A股异动 | 誉衡药业涨6.53% 控股股东所持全部7.06亿股将被拍卖 或将致控制权变化",
    "href": "http://stock.jrj.com.cn/2022/12/29111337245569.shtml",
    "datetime": "2022-12-29 11:13:47",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：控股股东所持全部7.06亿股将被拍卖",
    "href": "http://stock.jrj.com.cn/2022/12/28194337244147.shtml",
    "datetime": "2022-12-28 19:43:15",
    "code": "002437"
  },
  {
    "title": "誉衡药业：计提资产减值准备并对参股公司开发支出计提减值准备",
    "href": "http://stock.jrj.com.cn/2022/12/27193937241349.shtml",
    "datetime": "2022-12-27 19:39:40",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：598.05万股限售股12月19日解禁",
    "href": "http://stock.jrj.com.cn/2022/12/14170137212263.shtml",
    "datetime": "2022-12-14 17:01:12",
    "code": "002437"
  },
  {
    "title": "东北药王浮沉史：有人破产，有人入狱",
    "href": "http://stock.jrj.com.cn/2022/12/07173737195439.shtml",
    "datetime": "2022-12-07 17:37:50",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：控股股东被法院裁定终止重整程序并宣告破产",
    "href": "http://stock.jrj.com.cn/2022/11/11210037132806.shtml",
    "datetime": "2022-11-11 21:00:08",
    "code": "002437"
  },
  {
    "title": "誉衡药业2022年前三季度净利3010.48万同比下滑72.76% 政府补助下降",
    "href": "http://stock.jrj.com.cn/2022/10/26191237086745.shtml",
    "datetime": "2022-10-26 19:12:08",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)第三季度净利润323.43万元、同比增长179.38%",
    "href": "http://stock.jrj.com.cn/2022/10/26172637086158.shtml",
    "datetime": "2022-10-26 17:26:25",
    "code": "002437"
  },
  {
    "title": "誉衡药业：参股公司誉衡生物未涉及海外cxo业务 美国相关政策对其暂无影响",
    "href": "http://stock.jrj.com.cn/2022/09/13165336991454.shtml",
    "datetime": "2022-09-13 16:53:05",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)上半年净利2687.05万元 同比下降76.55%",
    "href": "http://stock.jrj.com.cn/2022/08/28163336944225.shtml",
    "datetime": "2022-08-28 16:33:54",
    "code": "002437"
  },
  {
    "title": "誉衡药业招采严重失信研发费两年降47% 销售费4.56亿畸高占营收59%靠出售房产增收",
    "href": "http://stock.jrj.com.cn/2022/07/18114036820366.shtml",
    "datetime": "2022-07-18 11:40:25",
    "code": "002437"
  },
  {
    "title": "誉衡药业2022年上半年预计净利2200万-3000万同比下降74%-81% 对参股公司投资亏损加大",
    "href": "http://stock.jrj.com.cn/2022/07/14211036812996.shtml",
    "datetime": "2022-07-14 21:10:54",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际、健康科技减持期过半未减持",
    "href": "http://stock.jrj.com.cn/2022/07/07162436791071.shtml",
    "datetime": "2022-07-07 16:24:19",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：子公司一立体仓库发生火灾事故 未有伤亡",
    "href": "http://stock.jrj.com.cn/2022/05/13184536647455.shtml",
    "datetime": "2022-05-13 18:45:45",
    "code": "002437"
  },
  {
    "title": "誉衡药业2022年第一季度净利99.83万同比下滑95.44% 产生银团贷款安排费",
    "href": "http://stock.jrj.com.cn/2022/05/03185036546079.shtml",
    "datetime": "2022-05-03 18:50:49",
    "code": "002437"
  },
  {
    "title": "誉衡药业2021年净利4504.2万同比减少88.74% 董事长王东绪薪酬190万",
    "href": "http://stock.jrj.com.cn/2022/04/26171336476374.shtml",
    "datetime": "2022-04-26 17:13:07",
    "code": "002437"
  },
  {
    "title": "誉衡药业股东减持3710.28万股 套现约8014.2万 2021年第三季度公司亏损407.42万",
    "href": "http://stock.jrj.com.cn/2022/04/06213036264751.shtml",
    "datetime": "2022-04-06 21:30:47",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际方面完成减持1.6878%股份",
    "href": "http://stock.jrj.com.cn/2022/04/06171736263197.shtml",
    "datetime": "2022-04-06 17:17:52",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：参股公司誉衡生物拟引入战投增资2亿元",
    "href": "http://stock.jrj.com.cn/2022/04/06171336263205.shtml",
    "datetime": "2022-04-06 17:13:41",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际、健康科技及其债权人拟合计减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/03/14165434824324.shtml",
    "datetime": "2022-03-14 16:54:36",
    "code": "002437"
  },
  {
    "title": "誉衡药业2021年预计净利4000万-6000万同比下降85%-90% 参股公司产品研发大幅增加",
    "href": "http://stock.jrj.com.cn/2022/01/29195234257833.shtml",
    "datetime": "2022-01-29 19:52:53",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际已减持3710.2788万股",
    "href": "http://stock.jrj.com.cn/2022/01/07171534134024.shtml",
    "datetime": "2022-01-07 17:15:45",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：实控人朱吉满7月至9月累计被动减持996.75万股",
    "href": "http://stock.jrj.com.cn/2021/11/29210333939975.shtml",
    "datetime": "2021-11-29 21:03:30",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：拟对参股公司誉衡生物增资4300万元",
    "href": "http://stock.jrj.com.cn/2021/11/29210033939954.shtml",
    "datetime": "2021-11-29 21:00:17",
    "code": "002437"
  },
  {
    "title": "誉衡生物实施股权激励引入有限合伙持股平台 誉衡药业(002437.SZ)放弃增资优先认缴权",
    "href": "http://stock.jrj.com.cn/2021/11/12173133841623.shtml",
    "datetime": "2021-11-12 17:31:26",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：副总经理朱洪斌辞职",
    "href": "http://stock.jrj.com.cn/2021/11/10195333832818.shtml",
    "datetime": "2021-11-10 19:53:28",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：实控人方面9月1日以来共减持1.16%股份",
    "href": "http://stock.jrj.com.cn/2021/11/10170233832100.shtml",
    "datetime": "2021-11-10 17:02:56",
    "code": "002437"
  },
  {
    "title": "誉衡药业：前三季度净利润1.11亿元，同比下降83.20%",
    "href": "http://stock.jrj.com.cn/2021/10/31233133785620.shtml",
    "datetime": "2021-10-31 23:31:21",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：前三季度净利预降82.58%-84.10%",
    "href": "http://stock.jrj.com.cn/2021/10/14224233693601.shtml",
    "datetime": "2021-10-14 22:42:08",
    "code": "002437"
  },
  {
    "title": "誉衡药业股东及其一致行动人拟减持不超1.32亿股公司股份 上半年公司净利1.15亿",
    "href": "http://stock.jrj.com.cn/2021/09/07193933399768.shtml",
    "datetime": "2021-09-07 19:39:35",
    "code": "002437"
  },
  {
    "title": "誉衡药业：誉衡国际及一致行动人或被动减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2021/09/07174333399161.shtml",
    "datetime": "2021-09-07 17:43:49",
    "code": "002437"
  },
  {
    "title": "誉衡药业：誉衡国际及一致行动人或被动减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2021/09/07170533398933.shtml",
    "datetime": "2021-09-07 17:05:32",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际及一致行动人或被动减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2021/09/07170033398901.shtml",
    "datetime": "2021-09-07 17:00:09",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：参股公司产品全人抗PD-1单克隆抗体注射液获批上市",
    "href": "http://stock.jrj.com.cn/2021/08/30194333354601.shtml",
    "datetime": "2021-08-30 19:43:15",
    "code": "002437"
  },
  {
    "title": "誉衡药业、药明生物联合开发的PD-1获批上市",
    "href": "http://stock.jrj.com.cn/2021/08/30141433351811.shtml",
    "datetime": "2021-08-30 14:14:33",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)上半年净利降82.87%至1.15亿元",
    "href": "http://stock.jrj.com.cn/2021/08/27174633334264.shtml",
    "datetime": "2021-08-27 17:46:40",
    "code": "002437"
  },
  {
    "title": "誉衡药业2021年半年度净利1.15亿元 同比净利减少82.87%",
    "href": "http://stock.jrj.com.cn/2021/08/27171733334035.shtml",
    "datetime": "2021-08-27 17:17:38",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际已累计被动减持1800万股",
    "href": "http://stock.jrj.com.cn/2021/07/27221033160020.shtml",
    "datetime": "2021-07-27 22:10:58",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)上修业绩预告：半年度预盈9000万-11000万元",
    "href": "http://stock.jrj.com.cn/2021/07/14161733094990.shtml",
    "datetime": "2021-07-14 16:17:43",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：减持期过半 股东誉衡国际、健康科技未减持股份",
    "href": "http://stock.jrj.com.cn/2021/07/08182733065220.shtml",
    "datetime": "2021-07-08 18:27:45",
    "code": "002437"
  },
  {
    "title": "誉衡药业：公司近年业绩下滑主要原因为受两票制政策、重点监控目录、医保控费等政策及新冠肺炎疫情影响",
    "href": "http://stock.jrj.com.cn/2021/06/24163132989988.shtml",
    "datetime": "2021-06-24 16:31:49",
    "code": "002437"
  },
  {
    "title": "誉衡药业：最近3个月 公司未接待投资者调研",
    "href": "http://stock.jrj.com.cn/2021/06/17140532947189.shtml",
    "datetime": "2021-06-17 14:05:50",
    "code": "002437"
  },
  {
    "title": "誉衡药业：利润下降主要原因为2020年出售澳诺（中国）制药有限公司100%股权获得投资收益所致",
    "href": "http://stock.jrj.com.cn/2021/06/09095332898028.shtml",
    "datetime": "2021-06-09 09:53:05",
    "code": "002437"
  },
  {
    "title": "誉衡药业：公司补达秀、安脑丸等属于院线及OTC双跨产品 目前也在积极布局非处方销售市场",
    "href": "http://stock.jrj.com.cn/2021/05/31204532852339.shtml",
    "datetime": "2021-05-31 20:45:23",
    "code": "002437"
  },
  {
    "title": "誉衡药业：公司控股股东破产重整目前尚无实质性进展",
    "href": "http://stock.jrj.com.cn/2021/05/31181932851355.shtml",
    "datetime": "2021-05-31 18:19:25",
    "code": "002437"
  },
  {
    "title": "誉衡药业：公司代理的日本明治透明质酸钠产品为骨性关节炎的治疗药物",
    "href": "http://stock.jrj.com.cn/2021/05/10161632729907.shtml",
    "datetime": "2021-05-10 16:16:14",
    "code": "002437"
  },
  {
    "title": "誉衡药业：公司未有参与抗击新冠肺炎相关计划",
    "href": "http://stock.jrj.com.cn/2021/04/28185732473190.shtml",
    "datetime": "2021-04-28 18:57:23",
    "code": "002437"
  },
  {
    "title": "誉衡药业：公司下属子公司不涉及医疗美容、生殖健康等项目",
    "href": "http://stock.jrj.com.cn/2021/04/19163032402393.shtml",
    "datetime": "2021-04-19 16:30:09",
    "code": "002437"
  },
  {
    "title": "誉衡药业2021年第一季度预计净利2000万-2500万 较上年同期下降96.2%-96.96%",
    "href": "http://stock.jrj.com.cn/2021/04/18133332393032.shtml",
    "datetime": "2021-04-18 13:33:31",
    "code": "002437"
  },
  {
    "title": "誉衡药业2020年度净利4亿 获得投资收益",
    "href": "http://stock.jrj.com.cn/2021/04/15190732381077.shtml",
    "datetime": "2021-04-15 19:07:40",
    "code": "002437"
  },
  {
    "title": "强平预警下股东减持 誉衡药业又子公司商业贿赂登通报",
    "href": "http://stock.jrj.com.cn/2021/04/14181732372884.shtml",
    "datetime": "2021-04-14 18:17:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业股东誉衡国际被动减持4206.74万股",
    "href": "http://stock.jrj.com.cn/2021/04/09092532339131.shtml",
    "datetime": "2021-04-09 09:25:07",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际已被动减持4206.74万股",
    "href": "http://stock.jrj.com.cn/2021/04/08193132333619.shtml",
    "datetime": "2021-04-08 19:31:09",
    "code": "002437"
  },
  {
    "title": "誉衡药业并购后遗症扣非两年亏29亿 朱吉满控制股权冻结率超90%面临风险",
    "href": "http://stock.jrj.com.cn/2021/03/12071632113074.shtml",
    "datetime": "2021-03-12 07:16:12",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：誉衡国际及其一致行动人可能减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2021/03/09171332098321.shtml",
    "datetime": "2021-03-09 17:13:53",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：股东誉衡国际被动减持1.28%股份",
    "href": "http://stock.jrj.com.cn/2021/01/11191631671728.shtml",
    "datetime": "2021-01-11 19:16:55",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)拟对誉衡生物进行第二轮增资",
    "href": "http://stock.jrj.com.cn/2020/12/25200431572252.shtml",
    "datetime": "2020-12-25 20:04:15",
    "code": "002437"
  },
  {
    "title": "誉衡药业(002437.SZ)：总经理隆万程辞职",
    "href": "http://stock.jrj.com.cn/2020/12/18174431519470.shtml",
    "datetime": "2020-12-18 17:44:22",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]再获殊荣!誉衡药业荣登2019年度中国医药工业百强榜",
    "href": "http://stock.jrj.com.cn/2020/11/20000031824325.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]缔造,合作,共赢 ——誉衡药业与济宁为民战略合作,为心血管用药布局再添一员",
    "href": "http://stock.jrj.com.cn/2020/11/20000031690454.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：pd1及控股股东重整均处于正常推进中",
    "href": "http://stock.jrj.com.cn/2020/11/12184231269049.shtml",
    "datetime": "2020-11-12 18:42:37",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2020年三季度公司销售费用率增长主要是澳诺制药不再纳入合并范围的影响",
    "href": "http://stock.jrj.com.cn/2020/11/12163131268152.shtml",
    "datetime": "2020-11-12 16:31:12",
    "code": "002437"
  },
  {
    "title": "誉衡药业：公司未来将重点推进营销改革、推进CMO平台建设及生物药领域等",
    "href": "http://stock.jrj.com.cn/2020/11/12155331267695.shtml",
    "datetime": "2020-11-12 15:53:41",
    "code": "002437"
  },
  {
    "title": "誉衡药业三季度亏损1132万元",
    "href": "http://stock.jrj.com.cn/2020/10/28094231148942.shtml",
    "datetime": "2020-10-28 09:42:13",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/28010031145733.shtml",
    "datetime": "2020-10-28 01:00:01",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]合力共赢,共创未来——誉衡药业与第一三共战略合作再升级",
    "href": "http://stock.jrj.com.cn/2020/10/28000031824326.shtml",
    "datetime": "2020-10-28 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]赛帕利单抗荣获指南II级专家推荐",
    "href": "http://stock.jrj.com.cn/2020/10/28000031383665.shtml",
    "datetime": "2020-10-28 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉东制药通过GMP符合性检查,新工艺产品正式投入市场",
    "href": "http://stock.jrj.com.cn/2020/10/28000031156984.shtml",
    "datetime": "2020-10-28 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业2020年前三季度净利6.4亿-6.7亿 出售股权获得相关收益",
    "href": "http://stock.jrj.com.cn/2020/10/15113031058745.shtml",
    "datetime": "2020-10-15 11:30:31",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2020年前三季度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/10/15081131057073.shtml",
    "datetime": "2020-10-15 08:11:21",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣登2020中国品牌价值评价信息榜",
    "href": "http://stock.jrj.com.cn/2020/10/15000031383667.shtml",
    "datetime": "2020-10-15 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]战略升级,合力共赢——誉衡药业与第一三共合作升级,共创未来",
    "href": "http://stock.jrj.com.cn/2020/10/15000031151214.shtml",
    "datetime": "2020-10-15 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业2名股东合计减持9908.1万股 套现约2.48亿元",
    "href": "http://stock.jrj.com.cn/2020/10/09204031012319.shtml",
    "datetime": "2020-10-09 20:40:37",
    "code": "002437"
  },
  {
    "title": "这家去年巨亏26亿的药企 控股股东要破产 被动减持超2900万股",
    "href": "http://stock.jrj.com.cn/2020/09/24072130822183.shtml",
    "datetime": "2020-09-24 07:21:18",
    "code": "002437"
  },
  {
    "title": "上市公司晚间利空汇总：誉衡药业股东拟减持不超过6％公司股份",
    "href": "http://stock.jrj.com.cn/2020/09/08181430705190.shtml",
    "datetime": "2020-09-08 18:14:24",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]致股东",
    "href": "http://stock.jrj.com.cn/2020/08/31000031383666.shtml",
    "datetime": "2020-08-31 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业2020年上半年净利6.69亿增长188.02% 营业成本下滑",
    "href": "http://stock.jrj.com.cn/2020/08/28181330615501.shtml",
    "datetime": "2020-08-28 18:13:19",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/08/27213030606781.shtml",
    "datetime": "2020-08-27 21:30:00",
    "code": "002437"
  },
  {
    "title": "大股东破产重整、扣非巨亏的誉衡药业股份遭“轮番”拍卖 未来路在何方？",
    "href": "http://stock.jrj.com.cn/2020/07/28082530360183.shtml",
    "datetime": "2020-07-28 08:25:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]再获殊荣!誉衡药业荣登2019年度中国医药工业百强榜",
    "href": "http://stock.jrj.com.cn/2020/07/23000030331991.shtml",
    "datetime": "2020-07-23 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]注射用磷酸肌酸钠入选《新型冠状病毒感染相关心肌损伤的临床管理专家建议》",
    "href": "http://stock.jrj.com.cn/2020/07/23000030647597.shtml",
    "datetime": "2020-07-23 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2020年半年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/07/15083030245839.shtml",
    "datetime": "2020-07-15 08:30:08",
    "code": "002437"
  },
  {
    "title": "誉衡药业2020年上半年预计净利6.5亿元-6.8亿元 出售股权获得的相关收益",
    "href": "http://stock.jrj.com.cn/2020/07/14213030241563.shtml",
    "datetime": "2020-07-14 21:30:20",
    "code": "002437"
  },
  {
    "title": "医药板块走强 誉衡药业、康辰药业双双拉升涨停",
    "href": "http://stock.jrj.com.cn/2020/07/09101030189016.shtml",
    "datetime": "2020-07-09 10:10:46",
    "code": "002437"
  },
  {
    "title": "誉衡药业与第一三共升级合作",
    "href": "http://stock.jrj.com.cn/2020/07/07214730170389.shtml",
    "datetime": "2020-07-07 21:47:04",
    "code": "002437"
  },
  {
    "title": "快讯：誉衡药业急速拉升5.95% 主力资金净流入926.47万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/07103230163921.shtml",
    "datetime": "2020-07-07 10:32:22",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]合力共赢,共创未来——誉衡药业与第一三共战略合作再升级",
    "href": "http://stock.jrj.com.cn/2020/07/07000030171774.shtml",
    "datetime": "2020-07-07 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]战疫情 献爱心,传真情——誉衡药业下属公司普德药业助力疫情阻击战",
    "href": "http://stock.jrj.com.cn/2020/07/07000030647589.shtml",
    "datetime": "2020-07-07 00:00:00",
    "code": "002437"
  },
  {
    "title": "快讯：誉衡药业急速拉升5.72% 主力资金净流入3336.63万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/06111330151721.shtml",
    "datetime": "2020-07-06 11:13:23",
    "code": "002437"
  },
  {
    "title": "控股股东屡次被迫减持 誉衡药业疯狂并购后的“深渊”仍未见底",
    "href": "http://stock.jrj.com.cn/2020/06/24075330007185.shtml",
    "datetime": "2020-06-24 07:53:00",
    "code": "002437"
  },
  {
    "title": "一场爆雷的并购案背后：一个首富的“过去式” 300多名投资人的心酸史",
    "href": "http://stock.jrj.com.cn/2020/06/04072229841425.shtml",
    "datetime": "2020-06-04 07:22:02",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]赛帕利单抗荣获指南II级专家推荐",
    "href": "http://stock.jrj.com.cn/2020/05/26000029767964.shtml",
    "datetime": "2020-05-26 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业参股公司誉衡生物抗PD-1单抗新药上市申请获国家药品监督管理局正式受理",
    "href": "http://stock.jrj.com.cn/2020/05/26000030647599.shtml",
    "datetime": "2020-05-26 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业安脑片助力辽宁疫情抗战",
    "href": "http://stock.jrj.com.cn/2020/05/13000030647591.shtml",
    "datetime": "2020-05-13 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣登2020中国品牌价值评价信息榜",
    "href": "http://stock.jrj.com.cn/2020/05/13000029662638.shtml",
    "datetime": "2020-05-13 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业总经理张大勇辞职 隆万程接任",
    "href": "http://stock.jrj.com.cn/2020/05/03180229502543.shtml",
    "datetime": "2020-05-03 18:02:21",
    "code": "002437"
  },
  {
    "title": "誉衡药业2020年第一季度净利6.59亿增长670.39% 销售费用投入减少所致",
    "href": "http://stock.jrj.com.cn/2020/05/01220829441553.shtml",
    "datetime": "2020-05-01 22:08:22",
    "code": "002437"
  },
  {
    "title": "誉衡药业2019年亏损26.62亿由盈转亏 公司业绩大幅下滑",
    "href": "http://stock.jrj.com.cn/2020/04/28215929408211.shtml",
    "datetime": "2020-04-28 21:59:05",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/28100029401780.shtml",
    "datetime": "2020-04-28 10:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]致股东",
    "href": "http://stock.jrj.com.cn/2020/04/28000029662637.shtml",
    "datetime": "2020-04-28 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业再向哈尔滨市疾病预防控制中心捐赠抗疫药品",
    "href": "http://stock.jrj.com.cn/2020/04/28000030647602.shtml",
    "datetime": "2020-04-28 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292297.shtml",
    "datetime": "2020-04-15 08:00:17",
    "code": "002437"
  },
  {
    "title": "誉衡药业2020年一季度预计净利6.3亿元-6.8亿元 同比增长636.94%-695.43%",
    "href": "http://stock.jrj.com.cn/2020/04/14235229287169.shtml",
    "datetime": "2020-04-14 23:52:59",
    "code": "002437"
  },
  {
    "title": "誉衡药业一季度净利润预增637%-695%",
    "href": "http://stock.jrj.com.cn/2020/04/14194429285684.shtml",
    "datetime": "2020-04-14 19:44:04",
    "code": "002437"
  },
  {
    "title": "誉衡药业：一季度净利预增637%-695%",
    "href": "http://stock.jrj.com.cn/2020/04/14185229285416.shtml",
    "datetime": "2020-04-14 18:52:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业2名股东合计减持4369万股 套现约1.15亿元",
    "href": "http://stock.jrj.com.cn/2020/04/07202329227871.shtml",
    "datetime": "2020-04-07 20:23:25",
    "code": "002437"
  },
  {
    "title": "“断臂自救”仍巨亏20多亿 誉衡药业并购“后遗症”如何治",
    "href": "http://stock.jrj.com.cn/2020/03/25081129102516.shtml",
    "datetime": "2020-03-25 08:11:37",
    "code": "002437"
  },
  {
    "title": "誉衡药业全资下属公司获得政府补助共计1391万元",
    "href": "http://stock.jrj.com.cn/2020/03/23211129085761.shtml",
    "datetime": "2020-03-23 21:11:53",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东及一致行动人拟减持不超6％股份",
    "href": "http://stock.jrj.com.cn/2020/03/13170929020835.shtml",
    "datetime": "2020-03-13 17:09:42",
    "code": "002437"
  },
  {
    "title": "制药板块业绩前瞻：誉衡药业、亚太药业亏损超20亿 行业利润增速放缓",
    "href": "http://stock.jrj.com.cn/2020/03/06073328964833.shtml",
    "datetime": "2020-03-06 07:33:30",
    "code": "002437"
  },
  {
    "title": "誉衡药业2019年亏损25.64亿 全资子公司主要产品销量不断下降",
    "href": "http://stock.jrj.com.cn/2020/02/29124228919342.shtml",
    "datetime": "2020-02-29 12:42:02",
    "code": "002437"
  },
  {
    "title": "誉衡药业累计捐赠物资达1000万元",
    "href": "http://stock.jrj.com.cn/2020/02/24185428883623.shtml",
    "datetime": "2020-02-24 18:54:22",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]战役情 献爱心,传真情——誉衡药业下属公司普德药业助力疫情阻击战",
    "href": "http://stock.jrj.com.cn/2020/02/24000028880743.shtml",
    "datetime": "2020-02-24 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]注射用磷酸肌酸钠入选《新型冠状病毒感染相关心肌损伤的临床管理专家建议》",
    "href": "http://stock.jrj.com.cn/2020/02/24000028880742.shtml",
    "datetime": "2020-02-24 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：参股公司抗PD-1单抗新药上市申请获国家药监局正式受理",
    "href": "http://stock.jrj.com.cn/2020/02/19131428854683.shtml",
    "datetime": "2020-02-19 13:14:26",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡生物抗PD-1单抗新药上市申请获国家药品监督管理局正式受理",
    "href": "http://stock.jrj.com.cn/2020/02/19000028854121.shtml",
    "datetime": "2020-02-19 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业为莱博通申请1.8亿元银行综合授信提供担保",
    "href": "http://stock.jrj.com.cn/2020/02/15095128832688.shtml",
    "datetime": "2020-02-15 09:51:42",
    "code": "002437"
  },
  {
    "title": "誉衡药业回复交易所问询：未通过大额计提调节利润",
    "href": "http://stock.jrj.com.cn/2020/02/12104728814302.shtml",
    "datetime": "2020-02-12 10:47:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业再向哈尔滨市疾病预防控制中心捐赠抗疫药品",
    "href": "http://stock.jrj.com.cn/2020/02/09000028800337.shtml",
    "datetime": "2020-02-09 00:00:00",
    "code": "002437"
  },
  {
    "title": "125只医药股业绩预喜 两成翻倍",
    "href": "http://stock.jrj.com.cn/2020/02/06042828778991.shtml",
    "datetime": "2020-02-06 04:28:30",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]抗疫情,勇担当——誉衡药业向湖北省数十家机构捐赠抗疫药品",
    "href": "http://stock.jrj.com.cn/2020/02/06000028790009.shtml",
    "datetime": "2020-02-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]抗疫情,勇担当——誉衡药业向湖北省数十家机构捐赠抗疫药品",
    "href": "http://stock.jrj.com.cn/2020/02/06000030647618.shtml",
    "datetime": "2020-02-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]朱吉满先生专访:本土药企的创新转型与国际化之路",
    "href": "http://stock.jrj.com.cn/2020/02/06000030406500.shtml",
    "datetime": "2020-02-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]Young!2020,誉青春——誉衡药业总部员工年会在京召开",
    "href": "http://stock.jrj.com.cn/2020/02/04000030406502.shtml",
    "datetime": "2020-02-04 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]抗疫情,勇担当——誉衡药业氯化钾缓释片(补达秀)火速进入火神山医院",
    "href": "http://stock.jrj.com.cn/2020/02/04000028767090.shtml",
    "datetime": "2020-02-04 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/30212028743764.shtml",
    "datetime": "2020-01-30 21:20:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2019年预亏24亿元至26亿元 商誉减值25亿元至27亿元",
    "href": "http://stock.jrj.com.cn/2020/01/30180228743402.shtml",
    "datetime": "2020-01-30 18:02:45",
    "code": "002437"
  },
  {
    "title": "誉衡药业：参股公司在研产品全人抗PD-1单克隆抗体注射液提交上市申请",
    "href": "http://stock.jrj.com.cn/2020/01/30174428743341.shtml",
    "datetime": "2020-01-30 17:44:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]朱吉满先生专访:本土药企的创新转型与国际化之路",
    "href": "http://stock.jrj.com.cn/2020/01/21000028714780.shtml",
    "datetime": "2020-01-21 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]补达秀:国内第一个通过一致性评价的内源性药物",
    "href": "http://stock.jrj.com.cn/2020/01/21000030102859.shtml",
    "datetime": "2020-01-21 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]中外医健翘楚聚首对话 共眺生物制药国际化未来——誉衡生物首次亮相美国旧金山JPM会议周",
    "href": "http://stock.jrj.com.cn/2020/01/21000030406505.shtml",
    "datetime": "2020-01-21 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]Young!2020,誉青春——誉衡药业总部员工年会在京召开",
    "href": "http://stock.jrj.com.cn/2020/01/20000028707552.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业:氯化钾缓释片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/20000030102858.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]整合、增效、拼业绩——誉衡药业2020年工作会议在京召开",
    "href": "http://stock.jrj.com.cn/2020/01/20000030406509.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]中外医健翘楚聚首对话 共眺生物制药国际化未来——誉衡生物首次亮相美国旧金山JPM会议周",
    "href": "http://stock.jrj.com.cn/2020/01/17000028691654.shtml",
    "datetime": "2020-01-17 00:00:00",
    "code": "002437"
  },
  {
    "title": "为减少未来5年采购款 誉衡药业赔钱终止供销合同",
    "href": "http://stock.jrj.com.cn/2020/01/13193528669026.shtml",
    "datetime": "2020-01-13 19:35:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获2018年度中国医药工业百强",
    "href": "http://stock.jrj.com.cn/2020/01/06000028932350.shtml",
    "datetime": "2020-01-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]整合、增效、拼业绩——誉衡药业2020年工作会议在京召开",
    "href": "http://stock.jrj.com.cn/2020/01/06000028632639.shtml",
    "datetime": "2020-01-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]携手共进、合作共赢——誉衡药业与第一三共战略合作再升级",
    "href": "http://stock.jrj.com.cn/2020/01/06000029163594.shtml",
    "datetime": "2020-01-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业跻身2019中国化学制药行业工业企业综合实力百强前三十",
    "href": "http://stock.jrj.com.cn/2020/01/06000029593812.shtml",
    "datetime": "2020-01-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣登2018年中国医药工业百强榜",
    "href": "http://stock.jrj.com.cn/2019/12/30000029163596.shtml",
    "datetime": "2019-12-30 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]补达秀:国内第一个通过一致性评价的内源性药物",
    "href": "http://stock.jrj.com.cn/2019/12/30000028603851.shtml",
    "datetime": "2019-12-30 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业:氯化钾缓释片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/27000028596779.shtml",
    "datetime": "2019-12-27 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]开疆拓土,关注中国特色瘤肿——誉衡生物GLS-010宫颈癌II期临床研究研究者会圆满召开",
    "href": "http://stock.jrj.com.cn/2019/12/27000029163592.shtml",
    "datetime": "2019-12-27 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：下属公司氯化钾缓释片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/26201728592156.shtml",
    "datetime": "2019-12-26 20:17:31",
    "code": "002437"
  },
  {
    "title": "誉衡药业：氯化钾缓释片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/26194928592043.shtml",
    "datetime": "2019-12-26 19:49:51",
    "code": "002437"
  },
  {
    "title": "誉衡药业回复深交所：出售澳诺制药 缓解流动性压力",
    "href": "http://stock.jrj.com.cn/2019/12/04114828487948.shtml",
    "datetime": "2019-12-04 11:48:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业溢价6倍“卖子”预计增利10亿 标的上半年贡献超三成净利润",
    "href": "http://stock.jrj.com.cn/2019/11/29082928466438.shtml",
    "datetime": "2019-11-29 08:29:44",
    "code": "002437"
  },
  {
    "title": "拟14.2亿元出售澳诺制药100%股权 誉衡药业涨停",
    "href": "http://stock.jrj.com.cn/2019/11/28093128461705.shtml",
    "datetime": "2019-11-28 09:31:40",
    "code": "002437"
  },
  {
    "title": "誉衡药业断臂求生 华润三九接纳澳诺制药",
    "href": "http://stock.jrj.com.cn/2019/11/28075528461341.shtml",
    "datetime": "2019-11-28 07:55:54",
    "code": "002437"
  },
  {
    "title": "誉衡药业转让澳诺药业100%股权 华润三九拟14.2亿接盘",
    "href": "http://stock.jrj.com.cn/2019/11/27212428459959.shtml",
    "datetime": "2019-11-27 21:24:43",
    "code": "002437"
  },
  {
    "title": "誉衡药业拟将澳诺（中国）制药100%股权转让给华润三九",
    "href": "http://stock.jrj.com.cn/2019/11/27184828459147.shtml",
    "datetime": "2019-11-27 18:48:16",
    "code": "002437"
  },
  {
    "title": "誉衡药业：拟14.2亿元转让澳诺制药100%股权给华润三九",
    "href": "http://stock.jrj.com.cn/2019/11/27184828459404.shtml",
    "datetime": "2019-11-27 18:48:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：拟14.2亿元出售澳诺制药100%股权",
    "href": "http://stock.jrj.com.cn/2019/11/27184128459096.shtml",
    "datetime": "2019-11-27 18:41:30",
    "code": "002437"
  },
  {
    "title": "8600万股强制拍卖 誉衡药业债务违约业绩下滑何时止？",
    "href": "http://stock.jrj.com.cn/2019/11/21091828430570.shtml",
    "datetime": "2019-11-21 09:18:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：天风证券2.34亿元竞得公司3.91%股份",
    "href": "http://stock.jrj.com.cn/2019/11/20173028427723.shtml",
    "datetime": "2019-11-20 17:30:01",
    "code": "002437"
  },
  {
    "title": "誉衡药业：天风证券竞得公司3.91%股份",
    "href": "http://stock.jrj.com.cn/2019/11/20172428427728.shtml",
    "datetime": "2019-11-20 17:24:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：誉衡国际所持公司2.82%股份被拍卖",
    "href": "http://stock.jrj.com.cn/2019/10/29172128318878.shtml",
    "datetime": "2019-10-29 17:21:49",
    "code": "002437"
  },
  {
    "title": "誉衡药业第三季度盈利7803万 同比下滑11%",
    "href": "http://stock.jrj.com.cn/2019/10/27205928305791.shtml",
    "datetime": "2019-10-27 20:59:15",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业跻身2019中国化学制药行业工业企业综合实力百强前三十",
    "href": "http://stock.jrj.com.cn/2019/10/11000028233066.shtml",
    "datetime": "2019-10-11 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]携手共进、合作共赢——誉衡药业与第一三共战略合作再升级",
    "href": "http://stock.jrj.com.cn/2019/09/17000028140046.shtml",
    "datetime": "2019-09-17 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获 2018年度中国医药工业百强等三大奖项",
    "href": "http://stock.jrj.com.cn/2019/09/17000029163595.shtml",
    "datetime": "2019-09-17 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东及一致行动人或被动减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/09/06214428102863.shtml",
    "datetime": "2019-09-06 21:44:14",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东及一致行动人可能被动减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/09/06195328102577.shtml",
    "datetime": "2019-09-06 19:53:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业2019年上半年净利2.32亿 不断优化销售渠道降低渠道产品库存",
    "href": "http://stock.jrj.com.cn/2019/08/27175928042056.shtml",
    "datetime": "2019-08-27 17:59:38",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获2018年度中国医药工业百强",
    "href": "http://stock.jrj.com.cn/2019/08/25000028033105.shtml",
    "datetime": "2019-08-25 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣登2018年中国医药工业百强榜",
    "href": "http://stock.jrj.com.cn/2019/08/25000028073739.shtml",
    "datetime": "2019-08-25 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业股东誉衡国际所持公司5.63%股份将被司法拍卖",
    "href": "http://stock.jrj.com.cn/2019/07/16194827848756.shtml",
    "datetime": "2019-07-16 19:48:32",
    "code": "002437"
  },
  {
    "title": "誉衡药业：誉衡国际所持公司5.63%股份将被司法拍卖",
    "href": "http://stock.jrj.com.cn/2019/07/16190827848650.shtml",
    "datetime": "2019-07-16 19:08:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣登2018年中国医药工业百强榜",
    "href": "http://stock.jrj.com.cn/2019/07/16000027851968.shtml",
    "datetime": "2019-07-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡生物PD-1单抗Ⅰb期临床研究数据亮相ASCO-GI 2019",
    "href": "http://stock.jrj.com.cn/2019/07/16000027913209.shtml",
    "datetime": "2019-07-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]开疆拓土,关注中国特色瘤肿——誉衡生物GLS-010宫颈癌II期临床研究研究者会圆满召开",
    "href": "http://stock.jrj.com.cn/2019/07/16000028073735.shtml",
    "datetime": "2019-07-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]开疆拓土,关注中国特色瘤肿——誉衡生物GLS-010宫颈癌II期临床研究研究者会圆满召开",
    "href": "http://stock.jrj.com.cn/2019/07/05000027802649.shtml",
    "datetime": "2019-07-05 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业2.35%销售净利率创新低 29亿销售费用占营收比过半",
    "href": "http://stock.jrj.com.cn/2019/06/25144827752873.shtml",
    "datetime": "2019-06-25 14:48:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业销售费用两年增26.7亿引质疑",
    "href": "http://stock.jrj.com.cn/2019/06/24080027746231.shtml",
    "datetime": "2019-06-24 08:00:19",
    "code": "002437"
  },
  {
    "title": "A股翻倍秘籍首次泄露！记住这7个口诀，炒股永不被套！",
    "href": "http://stock.jrj.com.cn/invest/2019/06/21181627739564.shtml",
    "datetime": "2019-06-21 18:16:35",
    "code": "002437"
  },
  {
    "title": "屏气凝神！A股连收诡异十字星，重磅节点来了！",
    "href": "http://stock.jrj.com.cn/invest/2019/06/18185727721092.shtml",
    "datetime": "2019-06-18 18:57:06",
    "code": "002437"
  },
  {
    "title": "19亿外资都看不下去了！大A股究竟在怂什么？",
    "href": "http://stock.jrj.com.cn/invest/2019/06/18165227720369.shtml",
    "datetime": "2019-06-18 16:52:17",
    "code": "002437"
  },
  {
    "title": "誉衡药业回复深交所问询：对政府补助不存在重大依赖",
    "href": "http://stock.jrj.com.cn/2019/06/17151127714723.shtml",
    "datetime": "2019-06-17 15:11:18",
    "code": "002437"
  },
  {
    "title": "紧急提醒！女科学家引爆A股！这9只才是最正宗青蒿素概念！",
    "href": "http://stock.jrj.com.cn/invest/2019/06/17115627713917.shtml",
    "datetime": "2019-06-17 11:56:54",
    "code": "002437"
  },
  {
    "title": "中药概念股大幅拉升 誉衡药业等7股涨停",
    "href": "http://stock.jrj.com.cn/2019/06/17094527713149.shtml",
    "datetime": "2019-06-17 09:45:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业问询函到期不复 最大股东冻结股份保全财产",
    "href": "http://stock.jrj.com.cn/2019/06/17071227712491.shtml",
    "datetime": "2019-06-17 07:12:09",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东所持公司股份新增轮候冻结约9.3亿股",
    "href": "http://stock.jrj.com.cn/2019/06/14210727706499.shtml",
    "datetime": "2019-06-14 21:07:34",
    "code": "002437"
  },
  {
    "title": "誉衡药业股东拟减持股份 预计合计减持不超总股本1%",
    "href": "http://stock.jrj.com.cn/2019/06/14075127702761.shtml",
    "datetime": "2019-06-14 07:51:24",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获 2018年度中国医药工业百强等三大奖项",
    "href": "http://stock.jrj.com.cn/2019/06/13000028073737.shtml",
    "datetime": "2019-06-13 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获 2018年度中国医药工业百强等三大奖项",
    "href": "http://stock.jrj.com.cn/2019/06/05000027668063.shtml",
    "datetime": "2019-06-05 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业PD-1单抗Ⅰ期临床研究数据亮相欧洲肿瘤内科学大会",
    "href": "http://stock.jrj.com.cn/2019/06/05000027776145.shtml",
    "datetime": "2019-06-05 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]药明康德新任首席医学官Frederick H. Hausheer博士来访誉衡生物",
    "href": "http://stock.jrj.com.cn/2019/06/05000028073734.shtml",
    "datetime": "2019-06-05 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]药明康德新任首席医学官Frederick H. Hausheer博士来访誉衡生物",
    "href": "http://stock.jrj.com.cn/2019/05/31000027646546.shtml",
    "datetime": "2019-05-31 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]哈尔滨市委书记王兆力莅临公司调研指导工作",
    "href": "http://stock.jrj.com.cn/2019/05/31000027776142.shtml",
    "datetime": "2019-05-31 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业拟发行中期票据 用于调整债务结构",
    "href": "http://stock.jrj.com.cn/2019/05/24152127618929.shtml",
    "datetime": "2019-05-24 15:21:29",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡磷酸肌酸获《2018中国心力衰竭诊断和治疗指南》推荐",
    "href": "http://stock.jrj.com.cn/2019/05/10000027776143.shtml",
    "datetime": "2019-05-10 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]中医药迎战略机遇 哈尔滨蒲公英药业借力资本腾飞",
    "href": "http://stock.jrj.com.cn/2019/05/10000028073733.shtml",
    "datetime": "2019-05-10 00:00:00",
    "code": "002437"
  },
  {
    "title": "一图读财报：誉衡药业2018年度营业总收入同比增长80.20%",
    "href": "http://stock.jrj.com.cn/2019/04/28004027498600.shtml",
    "datetime": "2019-04-28 00:40:32",
    "code": "002437"
  },
  {
    "title": "一图读财报：誉衡药业2018年度营业总收入同比增长80.20%",
    "href": "http://stock.jrj.com.cn/2019/04/25234027484664.shtml",
    "datetime": "2019-04-25 23:40:26",
    "code": "002437"
  },
  {
    "title": "一图读财报：誉衡药业2018年度营业总收入同比增长80.20%",
    "href": "http://stock.jrj.com.cn/2019/04/23224027469238.shtml",
    "datetime": "2019-04-23 22:40:25",
    "code": "002437"
  },
  {
    "title": "誉衡药业董事、副总经理李国春监事王禹双离职 李国春未持股 王禹继续担任职务",
    "href": "http://stock.jrj.com.cn/2019/04/22145027453863.shtml",
    "datetime": "2019-04-22 14:50:26",
    "code": "002437"
  },
  {
    "title": "誉衡药业副总经理李国春辞职 去年上半年营收同比增长101%",
    "href": "http://stock.jrj.com.cn/2019/04/22072027450750.shtml",
    "datetime": "2019-04-22 07:20:45",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]核心产品齐发力,誉衡药业战略布局初现成效",
    "href": "http://stock.jrj.com.cn/2019/04/16000027776144.shtml",
    "datetime": "2019-04-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]中医药迎战略机遇 哈尔滨蒲公英药业借力资本腾飞",
    "href": "http://stock.jrj.com.cn/2019/04/16000027408058.shtml",
    "datetime": "2019-04-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业][两会声音]朱吉满:“辅助用药”概念模糊 不再制定“辅助药品目录”",
    "href": "http://stock.jrj.com.cn/2019/04/16000028073732.shtml",
    "datetime": "2019-04-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "四家券商自营盘 “押中”科创板影子股",
    "href": "http://stock.jrj.com.cn/2019/03/27014727244960.shtml",
    "datetime": "2019-03-27 01:47:30",
    "code": "002437"
  },
  {
    "title": "科创板19只“影子股”12只逆市涨停 机构扎堆看好其中4只个股",
    "href": "http://stock.jrj.com.cn/2019/03/26044627235099.shtml",
    "datetime": "2019-03-26 04:46:27",
    "code": "002437"
  },
  {
    "title": "[誉衡药业][两会声音]朱吉满:“辅助用药”概念模糊 不再制定“辅助药品目录”",
    "href": "http://stock.jrj.com.cn/2019/03/12000027166300.shtml",
    "datetime": "2019-03-12 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业2018年净利1.27亿减少59% 计提资产减值3.8亿",
    "href": "http://stock.jrj.com.cn/2019/02/25224727086152.shtml",
    "datetime": "2019-02-25 22:47:58",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2018年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2019/01/30203027003497.shtml",
    "datetime": "2019-01-30 20:30:01",
    "code": "002437"
  },
  {
    "title": "誉衡药业2018年净利润上涨修正为下滑 拟计提商誉减值准备所致",
    "href": "http://stock.jrj.com.cn/2019/01/30194327003338.shtml",
    "datetime": "2019-01-30 19:43:51",
    "code": "002437"
  },
  {
    "title": "金洲慈航遭誉衡药业实控人起诉",
    "href": "http://stock.jrj.com.cn/2019/01/25014326954107.shtml",
    "datetime": "2019-01-25 01:43:37",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡生物PD-1单抗Ⅰb期临床研究数据亮相ASCO-GI 2019",
    "href": "http://stock.jrj.com.cn/2019/01/24000026952968.shtml",
    "datetime": "2019-01-24 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业PD-1单抗Ⅰ期临床研究数据亮相欧洲肿瘤内科学大会",
    "href": "http://stock.jrj.com.cn/2018/12/17000026777604.shtml",
    "datetime": "2018-12-17 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东及一致行动人拟被动减持不超过2%",
    "href": "http://stock.jrj.com.cn/2018/12/11191525540962.shtml",
    "datetime": "2018-12-11 19:15:17",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]哈尔滨市委书记王兆力莅临公司调研指导工作",
    "href": "http://stock.jrj.com.cn/2018/11/20000026777601.shtml",
    "datetime": "2018-11-20 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡磷酸肌酸获《2018中国心力衰竭诊断和治疗指南》推荐",
    "href": "http://stock.jrj.com.cn/2018/11/02000026777602.shtml",
    "datetime": "2018-11-02 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业多个产品入选基药目录",
    "href": "http://stock.jrj.com.cn/2018/10/29080925271278.shtml",
    "datetime": "2018-10-29 08:09:30",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]核心产品齐发力,誉衡药业战略布局初现成效",
    "href": "http://stock.jrj.com.cn/2018/10/27000026777598.shtml",
    "datetime": "2018-10-27 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：两产品进入国家基本药物目录",
    "href": "http://stock.jrj.com.cn/2018/10/26220025266161.shtml",
    "datetime": "2018-10-26 22:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获2018中国化学制药行业工业企业综合实力百强",
    "href": "http://stock.jrj.com.cn/2018/10/16000026777605.shtml",
    "datetime": "2018-10-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "终止筹划重大资产重组 誉衡药业低开高走涨振幅超10%",
    "href": "http://stock.jrj.com.cn/2018/09/27144925144388.shtml",
    "datetime": "2018-09-27 14:49:11",
    "code": "002437"
  },
  {
    "title": "晚间利空公告：誉衡药业终止筹划重大资产重组",
    "href": "http://stock.jrj.com.cn/2018/09/26193425140722.shtml",
    "datetime": "2018-09-26 19:34:49",
    "code": "002437"
  },
  {
    "title": "誉衡药业终止筹划重大资产重组事项",
    "href": "http://stock.jrj.com.cn/2018/09/26181225140379.shtml",
    "datetime": "2018-09-26 18:12:10",
    "code": "002437"
  },
  {
    "title": "誉衡药业：终止筹划重大资产重组",
    "href": "http://stock.jrj.com.cn/2018/09/26175225140234.shtml",
    "datetime": "2018-09-26 17:52:57",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡PD-1首次亮相2018 CSCO I期临床研究数据成绩喜人",
    "href": "http://stock.jrj.com.cn/2018/09/22000026777597.shtml",
    "datetime": "2018-09-22 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业商誉减值风险：残暴的欢愉终将以残暴为结局",
    "href": "http://stock.jrj.com.cn/2018/08/27193025007024.shtml",
    "datetime": "2018-08-27 19:30:46",
    "code": "002437"
  },
  {
    "title": "朱吉满130亿掘金败局：16亿断臂自救 誉衡药业12亿销售费占营收过半",
    "href": "http://stock.jrj.com.cn/2018/08/27063225002424.shtml",
    "datetime": "2018-08-27 06:32:07",
    "code": "002437"
  },
  {
    "title": "誉衡药业控股股东断臂求生 三知名接盘方为何甘当配角",
    "href": "http://stock.jrj.com.cn/2018/08/18075024969148.shtml",
    "datetime": "2018-08-18 07:50:24",
    "code": "002437"
  },
  {
    "title": "誉衡药业拟作价12.75亿元转让15%股份 引入战略投资者加速公司转型",
    "href": "http://stock.jrj.com.cn/2018/08/17095124965636.shtml",
    "datetime": "2018-08-17 09:51:00",
    "code": "002437"
  },
  {
    "title": "早间公告：誉衡药业控股股东拟转让15%股份；大烨智能并购苏州国宇",
    "href": "http://stock.jrj.com.cn/2018/08/17083524965223.shtml",
    "datetime": "2018-08-17 08:35:00",
    "code": "002437"
  },
  {
    "title": "8月17日早间公告集锦:誉衡药业控股股东拟转让15%股份",
    "href": "http://stock.jrj.com.cn/2018/08/17082024965115.shtml",
    "datetime": "2018-08-17 08:20:05",
    "code": "002437"
  },
  {
    "title": "[哈药股份]誉衡药业终止收购天麦生物股权",
    "href": "http://stock.jrj.com.cn/2018/08/16000024962196.shtml",
    "datetime": "2018-08-16 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业终止重组吃跌停 实控人质押14亿股商誉36亿",
    "href": "http://stock.jrj.com.cn/2018/08/13132424944374.shtml",
    "datetime": "2018-08-13 13:24:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：关于终止重大资产重组暨股票复牌的公告",
    "href": "http://stock.jrj.com.cn/2018/08/10210024939159.shtml",
    "datetime": "2018-08-10 21:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业上半年业绩回升明显 三季度有望持续增长",
    "href": "http://stock.jrj.com.cn/2018/08/06000026777600.shtml",
    "datetime": "2018-08-06 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/03192024903370.shtml",
    "datetime": "2018-08-03 19:20:00",
    "code": "002437"
  },
  {
    "title": "[哈药股份]40亿!誉衡药业要购买营业额144万元的公司",
    "href": "http://stock.jrj.com.cn/2018/07/12000024828448.shtml",
    "datetime": "2018-07-12 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业终止收购计划 1.8亿元保证金归期未知",
    "href": "http://stock.jrj.com.cn/2018/07/06022424776516.shtml",
    "datetime": "2018-07-06 02:24:30",
    "code": "002437"
  },
  {
    "title": "上市公司价值观查：誉衡药业广撒网式并购带来什么？",
    "href": "http://stock.jrj.com.cn/2018/07/05171524775005.shtml",
    "datetime": "2018-07-05 17:15:23",
    "code": "002437"
  },
  {
    "title": "交易对手“赖账”？ 誉衡药业1.8亿收购保证金收回难",
    "href": "http://stock.jrj.com.cn/2018/07/05011024770305.shtml",
    "datetime": "2018-07-05 01:10:08",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]大健康成新蓝海 誉衡药业“掘金”慢病药品",
    "href": "http://stock.jrj.com.cn/2018/07/05000026777603.shtml",
    "datetime": "2018-07-05 00:00:00",
    "code": "002437"
  },
  {
    "title": "交易对手“赖账”？ 誉衡药业1.8亿元收购保证金收回难",
    "href": "http://stock.jrj.com.cn/2018/07/04232224770061.shtml",
    "datetime": "2018-07-04 23:22:27",
    "code": "002437"
  },
  {
    "title": "誉衡药业：交易对方未按期退还1.8亿元收购保证金",
    "href": "http://stock.jrj.com.cn/2018/07/04092824766625.shtml",
    "datetime": "2018-07-04 09:28:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣登“中国制药工业百强”",
    "href": "http://stock.jrj.com.cn/2018/07/04000026777611.shtml",
    "datetime": "2018-07-04 00:00:00",
    "code": "002437"
  },
  {
    "title": "高质押炸雷、4个月17次停牌公告 朱吉满能守住江山吗",
    "href": "http://stock.jrj.com.cn/2018/06/29070524744130.shtml",
    "datetime": "2018-06-29 07:05:42",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获2017年度中国医药工业百强",
    "href": "http://stock.jrj.com.cn/2018/06/26000026777599.shtml",
    "datetime": "2018-06-26 00:00:00",
    "code": "002437"
  },
  {
    "title": "多家药企积极布局慢病市场",
    "href": "http://stock.jrj.com.cn/2018/06/19024824692986.shtml",
    "datetime": "2018-06-19 02:48:41",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]严控质量,聚力前行:誉衡药业PD-1启动关键注册上市研究",
    "href": "http://stock.jrj.com.cn/2018/06/19000026777613.shtml",
    "datetime": "2018-06-19 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业被疑滥用停牌收到《关注函》",
    "href": "http://stock.jrj.com.cn/2018/06/14005124677714.shtml",
    "datetime": "2018-06-14 00:51:07",
    "code": "002437"
  },
  {
    "title": "[天眼]誉衡药业重组又掀“新篇章” 复牌不足15交易日",
    "href": "http://stock.jrj.com.cn/2018/06/13164724675965.shtml",
    "datetime": "2018-06-13 16:47:38",
    "code": "002437"
  },
  {
    "title": "誉衡药业拟40亿购天麦生物 交易对方承诺3年净利18亿",
    "href": "http://stock.jrj.com.cn/2018/06/12030624666058.shtml",
    "datetime": "2018-06-12 03:06:05",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东终止筹划引入战投事项 被动减持170万股",
    "href": "http://stock.jrj.com.cn/2018/06/11203024665225.shtml",
    "datetime": "2018-06-11 20:30:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东终止筹划引入战投事项",
    "href": "http://stock.jrj.com.cn/2018/06/11202924665212.shtml",
    "datetime": "2018-06-11 20:29:42",
    "code": "002437"
  },
  {
    "title": "誉衡药业：控股股东及一致行动人或被动减持4396万股",
    "href": "http://stock.jrj.com.cn/2018/06/07211424652367.shtml",
    "datetime": "2018-06-07 21:14:35",
    "code": "002437"
  },
  {
    "title": "誉衡药业回复深交所关注函：控股股东及实控人积极筹款",
    "href": "http://stock.jrj.com.cn/2018/05/30194124613177.shtml",
    "datetime": "2018-05-30 19:41:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业与药明生物战略合作重磅升级",
    "href": "http://stock.jrj.com.cn/2018/05/29000026777612.shtml",
    "datetime": "2018-05-29 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]锌钙特入围2018年健康中国·品牌榜候选名单",
    "href": "http://stock.jrj.com.cn/2018/05/29000026777615.shtml",
    "datetime": "2018-05-29 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]澳诺与京东大药房战略合作,共建智慧大健康服务平台",
    "href": "http://stock.jrj.com.cn/2018/05/25000026777614.shtml",
    "datetime": "2018-05-25 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业50亿并购埋暗雷 新实控人能否扛得住？",
    "href": "http://stock.jrj.com.cn/2018/05/24075024583347.shtml",
    "datetime": "2018-05-24 07:50:07",
    "code": "002437"
  },
  {
    "title": "中健投有望入主 誉衡药业大股东暂解平仓危机",
    "href": "http://stock.jrj.com.cn/2018/05/24002624581766.shtml",
    "datetime": "2018-05-24 00:26:36",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]药明康德11连板市值破800亿元,誉衡药业复牌首日涨停,两家深度合作企业借生物药将继续向阳",
    "href": "http://stock.jrj.com.cn/2018/05/23000026777610.shtml",
    "datetime": "2018-05-23 00:00:00",
    "code": "002437"
  },
  {
    "title": "医药板块再度强势领涨 誉衡药业涨停",
    "href": "http://stock.jrj.com.cn/2018/05/22103624572880.shtml",
    "datetime": "2018-05-22 10:36:00",
    "code": "002437"
  },
  {
    "title": "拟引入战略投资者 誉衡药业股价开盘涨停",
    "href": "http://stock.jrj.com.cn/2018/05/22100824572698.shtml",
    "datetime": "2018-05-22 10:08:01",
    "code": "002437"
  },
  {
    "title": "誉衡药业：实控人正就引入战投事项与中健投磋商",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/22075924571937.shtml",
    "datetime": "2018-05-22 07:59:59",
    "code": "002437"
  },
  {
    "title": "重组及战投引入工作继续推进誉衡药业宣布复牌 大股东债务危局仍然待解",
    "href": "http://stock.jrj.com.cn/2018/05/21215924570330.shtml",
    "datetime": "2018-05-21 21:59:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：复牌公告",
    "href": "http://stock.jrj.com.cn/2018/05/21203024569983.shtml",
    "datetime": "2018-05-21 20:30:01",
    "code": "002437"
  },
  {
    "title": "誉衡药业：实控人正就引入战投事项与中健投磋商 22日复牌",
    "href": "http://stock.jrj.com.cn/2018/05/21202724569995.shtml",
    "datetime": "2018-05-21 20:27:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：实控人正就引入战投事项与中健投磋商 明日复牌",
    "href": "http://stock.jrj.com.cn/2018/05/21193024569785.shtml",
    "datetime": "2018-05-21 19:30:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业与微医云携手共建基层医疗云平台",
    "href": "http://stock.jrj.com.cn/2018/05/19000026777609.shtml",
    "datetime": "2018-05-19 00:00:00",
    "code": "002437"
  },
  {
    "title": "实控人受困资金 誉衡药业控制权或生变",
    "href": "http://stock.jrj.com.cn/2018/05/15142724541928.shtml",
    "datetime": "2018-05-15 14:27:22",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]药明生物全球扩充产能 抢占PD1赛道制高点",
    "href": "http://stock.jrj.com.cn/2018/05/14000026777607.shtml",
    "datetime": "2018-05-14 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]药明康德A股上市,揭密它在生物药创新模式的第一单",
    "href": "http://stock.jrj.com.cn/2018/05/09000026777608.shtml",
    "datetime": "2018-05-09 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业2017年营收超30亿 重点推进生物药、慢性病大健康",
    "href": "http://stock.jrj.com.cn/2018/04/26000026777606.shtml",
    "datetime": "2018-04-26 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/25220024452139.shtml",
    "datetime": "2018-04-25 22:00:00",
    "code": "002437"
  },
  {
    "title": "[天眼]誉衡药业43%股份冻结 实控人朱吉满被要求自查",
    "href": "http://stock.jrj.com.cn/2018/04/16215524397575.shtml",
    "datetime": "2018-04-16 21:55:07",
    "code": "002437"
  },
  {
    "title": "誉衡药业信邦制药部分股权被冻结 涉及市值约90亿",
    "href": "http://stock.jrj.com.cn/2018/04/13014524383383.shtml",
    "datetime": "2018-04-13 01:45:29",
    "code": "002437"
  },
  {
    "title": "誉衡药业：关于筹划重大资产重组的停牌公告",
    "href": "http://stock.jrj.com.cn/2018/02/21172024131825.shtml",
    "datetime": "2018-02-21 17:20:00",
    "code": "002437"
  },
  {
    "title": "[哈药股份]誉衡药业16亿收购卖POS机的支付领域企业",
    "href": "http://stock.jrj.com.cn/2017/12/21000023831294.shtml",
    "datetime": "2017-12-21 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：拟16亿元收购支付领域企业瑾呈集团70%股权",
    "href": "http://stock.jrj.com.cn/2017/12/19183023818383.shtml",
    "datetime": "2017-12-19 18:30:00",
    "code": "002437"
  },
  {
    "title": "交易提示：森源电气、誉衡药业等临时停牌",
    "href": "http://stock.jrj.com.cn/2017/12/07092523754345.shtml",
    "datetime": "2017-12-07 09:25:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：拟合作开发抗LAG3全人创新抗体药",
    "href": "http://stock.jrj.com.cn/hotstock/2017/11/27080023698371.shtml",
    "datetime": "2017-11-27 08:00:01",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业、药明生物再度联手,合作开发抗LAG3全人创新抗体药",
    "href": "http://stock.jrj.com.cn/2017/11/24000023750599.shtml",
    "datetime": "2017-11-24 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]“会说话”的智能药片——誉衡药业用科技引领未来",
    "href": "http://stock.jrj.com.cn/2017/11/15000023750600.shtml",
    "datetime": "2017-11-15 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业获评中国化药工业综合实力百强",
    "href": "http://stock.jrj.com.cn/2017/11/14000023750597.shtml",
    "datetime": "2017-11-14 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡基因“万人肿瘤免疫方舟计划发布会”隆重举行",
    "href": "http://stock.jrj.com.cn/2017/10/27000023750601.shtml",
    "datetime": "2017-10-27 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业蝉联工信部“中国医药工业百强”",
    "href": "http://stock.jrj.com.cn/2017/09/03000023750598.shtml",
    "datetime": "2017-09-03 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业：2017年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/08/25172023002668.shtml",
    "datetime": "2017-08-25 17:20:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]首届黑龙江省人民政府质量奖评审结果公示 18个企业(组织)入列拟授奖名单",
    "href": "http://stock.jrj.com.cn/2017/07/14000023750596.shtml",
    "datetime": "2017-07-14 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业入选“中国制药工业百强”",
    "href": "http://stock.jrj.com.cn/2017/06/30000023750594.shtml",
    "datetime": "2017-06-30 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]誉衡药业荣获“2016年度中国医药制造业百强”等三项大奖",
    "href": "http://stock.jrj.com.cn/2017/06/21000023750606.shtml",
    "datetime": "2017-06-21 00:00:00",
    "code": "002437"
  },
  {
    "title": "30亿入主信邦制药 誉衡药业老板再下一城",
    "href": "http://stock.jrj.com.cn/2017/05/11145922464577.shtml",
    "datetime": "2017-05-11 14:59:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]致股东",
    "href": "http://stock.jrj.com.cn/2017/05/09000023750603.shtml",
    "datetime": "2017-05-09 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]安全用药,生命护航 ——誉衡药业独家赞助大型科普纪录片《命悬一线》",
    "href": "http://stock.jrj.com.cn/2017/03/25000023750604.shtml",
    "datetime": "2017-03-25 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]抗PD-1全人创新抗体药GLS-010注射液获得临床批件",
    "href": "http://stock.jrj.com.cn/2017/03/20000023750605.shtml",
    "datetime": "2017-03-20 00:00:00",
    "code": "002437"
  },
  {
    "title": "[誉衡药业]澳诺制药举行综合车间落成典礼",
    "href": "http://stock.jrj.com.cn/2017/01/07000023750602.shtml",
    "datetime": "2017-01-07 00:00:00",
    "code": "002437"
  },
  {
    "title": "誉衡药业控股东累计质押7.02亿股公司股份",
    "href": "http://stock.jrj.com.cn/2016/11/10182321692373.shtml",
    "datetime": "2016-11-10 18:23:33",
    "code": "002437"
  },
  {
    "title": "誉衡药业投资基金参与万达私有化 午后触及涨停",
    "href": "http://stock.jrj.com.cn/2016/08/19132721341715.shtml",
    "datetime": "2016-08-19 13:27:19",
    "code": "002437"
  },
  {
    "title": "誉衡药业：拟使用不超过8500万美元投资国外优质医",
    "href": "http://stock.jrj.com.cn/hotstock/2016/06/07075921043959.shtml",
    "datetime": "2016-06-07 07:59:58",
    "code": "002437"
  },
  {
    "title": "誉衡药业终止独家销售代理注射用黄芪多糖",
    "href": "http://stock.jrj.com.cn/2016/06/01203221026267.shtml",
    "datetime": "2016-06-01 20:32:07",
    "code": "002437"
  },
  {
    "title": "誉衡药业控股股东持有的部分公司股份被质押",
    "href": "http://stock.jrj.com.cn/2016/03/29183120756463.shtml",
    "datetime": "2016-03-29 18:31:46",
    "code": "002437"
  }
]